THEOPHYLLINE

THEOPHYLLINE was reported 12467 times

THEOPHYLLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 65 0.9286
1 RIGHT ATRIAL HYPERTROPHY 79 0.7182
2 ANTASTHMATIC DRUG LEVEL ABOVE THERAPEUTIC 16 0.6667
3 HEART SOUNDS 59 0.6146
4 ANTACID THERAPY 47 0.3615
5 DECREASED BRONCHIAL SECRETION 14 0.3590
6 OCCUPATIONAL ASTHMA 19 0.3276
7 BRONCHIAL NEOPLASM 40 0.2941
8 RHINITIS PERENNIAL 22 0.2750
9 SLEEP DISORDER THERAPY 54 0.2727
10 PROLONGED EXPIRATION 60 0.2290
11 ANALGESIC THERAPY 64 0.1994
12 APPENDICOLITH 71 0.1835
13 DRUG THERAPY 60 0.1770
14 ANTICOAGULANT THERAPY 44 0.1549
15 NASAL OEDEMA 250 0.1383
16 BRONCHIAL HAEMORRHAGE 43 0.1378
17 ADULTERATED PRODUCT 26 0.1300
18 BRONCHIAL WALL THICKENING 89 0.1238
19 PRODUCT ADMINISTRATION ISSUE 23 0.1100
20 ENDOMETRIAL ABLATION 39 0.1092
21 NASAL TURBINATE HYPERTROPHY 41 0.1088
22 VITAL CAPACITY DECREASED 43 0.0960
23 AIRWAY PEAK PRESSURE INCREASED 14 0.0921
24 INTUBATION 22 0.0880
25 RIGHT VENTRICULAR HYPERTROPHY 79 0.0875
26 REVERSIBLE AIRWAYS OBSTRUCTION 40 0.0787
27 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 25 0.0720
28 OLIGOARTHRITIS 14 0.0704
29 BRONCHIAL SECRETION RETENTION 88 0.0691
30 CONGENITAL HIATUS HERNIA 15 0.0658
31 STATUS ASTHMATICUS 30 0.0636
32 MALIGNANT MELANOMA STAGE 0 13 0.0622
33 NIKOLSKY'S SIGN 10 0.0552
34 BREAST CONSERVING SURGERY 28 0.0547
35 TRISOMY 18 20 0.0525
36 PULMONARY FUNCTION TEST ABNORMAL 81 0.0520
37 AORTIC VALVE STENOSIS 89 0.0499
38 RHONCHI 63 0.0456
39 OESOPHAGEAL DILATATION 19 0.0430
40 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 39 0.0421
41 LUNG HYPERINFLATION 31 0.0360
42 TOTAL LUNG CAPACITY ABNORMAL 14 0.0360
43 EPIDURAL LIPOMATOSIS 12 0.0349
44 BRONCHIAL OBSTRUCTION 49 0.0349
45 FEMALE STERILISATION 17 0.0331
46 WEANING FAILURE 12 0.0330
47 HYPERPHOSPHATAEMIA 70 0.0325
48 FORCED EXPIRATORY VOLUME DECREASED 89 0.0314
49 PCO2 INCREASED 22 0.0309
50 PULMONARY ARTERY DILATATION 10 0.0291
51 OBSTRUCTION 114 0.0285
52 PULMONARY PAIN 83 0.0284
53 ALVEOLAR OSTEITIS 12 0.0284
54 URINARY TRACT DISCOMFORT 13 0.0282
55 CHEST X-RAY ABNORMAL 86 0.0280
56 BRONCHIAL DISORDER 43 0.0276
57 DIASTOLIC DYSFUNCTION 85 0.0275
58 TOTAL LUNG CAPACITY DECREASED 43 0.0269
59 ALLERGIC GRANULOMATOUS ANGIITIS 22 0.0268
60 ADJUSTMENT DISORDER 34 0.0262
61 FORCED VITAL CAPACITY DECREASED 17 0.0260
62 MENTAL DISABILITY 15 0.0260
63 BLOOD PHOSPHORUS INCREASED 66 0.0241
64 RALES 139 0.0239
65 WHEEZING 1411 0.0238
66 OBSTRUCTIVE AIRWAYS DISORDER 260 0.0233
67 DYSPNOEA EXACERBATED 12 0.0233
68 LUNG OPACITY 61 0.0231
69 MULTIPLE DRUG THERAPY 17 0.0225
70 FEBRILE CONVULSION 27 0.0221
71 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 14 0.0218
72 FULL BLOOD COUNT ABNORMAL 225 0.0213
73 FOETAL MALFORMATION 23 0.0212
74 BREATH SOUNDS ABNORMAL 102 0.0207
75 BENIGN PROSTATIC HYPERPLASIA 106 0.0205
76 SPUTUM RETENTION 19 0.0192
77 BRONCHIECTASIS 127 0.0188
78 DILATED CARDIOMYOPATHY 19 0.0188
79 HYPERCAPNIA 56 0.0186
80 PO2 DECREASED 21 0.0183
81 ALLERGIC COUGH 14 0.0182
82 SPUTUM ABNORMAL 12 0.0181
83 ASTHMA 2042 0.0180
84 OROPHARYNGEAL CANDIDIASIS 16 0.0177
85 STRESS URINARY INCONTINENCE 19 0.0177
86 PERFUME SENSITIVITY 10 0.0176
87 RESPIRATORY TRACT INFECTION 455 0.0175
88 DEPRESSIVE SYMPTOM 61 0.0173
89 AORTIC STENOSIS 59 0.0169
90 ACCIDENTAL DEATH 30 0.0161
91 INCREASED VISCOSITY OF BRONCHIAL SECRETION 10 0.0157
92 SPUTUM DISCOLOURED 141 0.0149
93 OEDEMA 804 0.0148
94 BLOOD IMMUNOGLOBULIN E INCREASED 35 0.0144
95 BRONCHITIS CHRONIC 35 0.0143
96 STAPHYLOCOCCUS TEST POSITIVE 30 0.0142
97 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 235 0.0138
98 SEPSIS NEONATAL 11 0.0135
99 BLOOD PH DECREASED 23 0.0134
100 EOSINOPHIL COUNT ABNORMAL 10 0.0134
101 ANIMAL SCRATCH 13 0.0134
102 SINUS PAIN 31 0.0133
103 IRON DEFICIENCY 58 0.0129
104 BLOOD BICARBONATE DECREASED 24 0.0127
105 CARBON DIOXIDE INCREASED 17 0.0125
106 GRANULOMA 43 0.0124
107 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 629 0.0120
108 DIZZINESS EXERTIONAL 9 0.0118
109 BLOOD URIC ACID INCREASED 67 0.0116
110 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 58 0.0114
111 RESPIRATORY ACIDOSIS 45 0.0114
112 RESPIRATION ABNORMAL 74 0.0107
113 RESPIRATORY SYMPTOM 30 0.0105
114 LEFT VENTRICULAR FAILURE 36 0.0104
115 APPETITE DISORDER 68 0.0102
116 INTERVERTEBRAL DISC DEGENERATION 89 0.0096
117 INCREASED BRONCHIAL SECRETION 24 0.0094
118 HYPOPHOSPHATAEMIA 68 0.0092
119 LOBAR PNEUMONIA 17 0.0092
120 CALCULUS URINARY 14 0.0091
121 PRODUCTIVE COUGH 433 0.0091
122 STATUS EPILEPTICUS 101 0.0089
123 GOUT 160 0.0089
124 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 18 0.0088
125 CONDUCTION DISORDER 16 0.0087
126 PULMONARY FUNCTION TEST DECREASED 38 0.0087
127 RESPIRATORY ALKALOSIS 14 0.0086
128 HYPOVENTILATION 28 0.0086
129 VENTRICULAR FIBRILLATION 95 0.0085
130 DRUG LEVEL ABOVE THERAPEUTIC 39 0.0085
131 TONIC CONVULSION 12 0.0085
132 SINUS TACHYCARDIA 120 0.0084
133 EMPHYSEMA 85 0.0084
134 PAINFUL RESPIRATION 20 0.0083
135 OBESITY 132 0.0083
136 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 18 0.0082
137 TACHYARRHYTHMIA 20 0.0080
138 RHINITIS 64 0.0079
139 APPENDICITIS 74 0.0079
140 MULTIPLE DRUG OVERDOSE 39 0.0079
141 SLEEP APNOEA SYNDROME 149 0.0078
142 BLOOD COUNT ABNORMAL 117 0.0077
143 ENCEPHALITIS AUTOIMMUNE 10 0.0076
144 PARANASAL SINUS HYPERSECRETION 29 0.0076
145 MYASTHENIA GRAVIS 61 0.0075
146 TUNNEL VISION 14 0.0075
147 CHRONIC RESPIRATORY FAILURE 9 0.0075
148 SPUTUM INCREASED 16 0.0074
149 LATENT TUBERCULOSIS 15 0.0072
150 SUPRAVENTRICULAR EXTRASYSTOLES 24 0.0071
151 FLANK PAIN 65 0.0069
152 SMALL INTESTINAL PERFORATION 13 0.0069
153 LOWER RESPIRATORY TRACT INFECTION 314 0.0069
154 DYSPNOEA EXERTIONAL 257 0.0068
155 NORMOCYTIC ANAEMIA 10 0.0068
156 HYPERCHOLESTEROLAEMIA 65 0.0067
157 DRUG TOXICITY 90 0.0066
158 AORTIC ARTERIOSCLEROSIS 17 0.0066
159 HYPERAEMIA 13 0.0066
160 EOSINOPHIL COUNT INCREASED 54 0.0065
161 GLOSSITIS 23 0.0065
162 BLOOD CALCIUM INCREASED 56 0.0064
163 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 305 0.0063
164 DRUG LEVEL INCREASED 103 0.0062
165 EOSINOPHILIC PNEUMONIA 19 0.0060
166 QUADRIPARESIS 10 0.0060
167 THERAPEUTIC AGENT TOXICITY 20 0.0060
168 HYPERLIPIDAEMIA 71 0.0059
169 CUSHINGOID 19 0.0059
170 TROPONIN INCREASED 45 0.0059
171 MULTIPLE DRUG OVERDOSE INTENTIONAL 19 0.0059
172 RESPIRATORY RATE INCREASED 52 0.0059
173 GASTROINTESTINAL NECROSIS 17 0.0058
174 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 414 0.0058
175 CAPILLARY LEAK SYNDROME 12 0.0058
176 PLEURITIC PAIN 16 0.0058
177 SUPRAVENTRICULAR TACHYCARDIA 55 0.0057
178 HYPERVENTILATION 33 0.0057
179 POLYMYALGIA RHEUMATICA 18 0.0057
180 AFFECTIVE DISORDER 44 0.0056
181 EAR CONGESTION 15 0.0055
182 GLAUCOMA 106 0.0055
183 ASTHMATIC CRISIS 20 0.0055
184 VENTRICULAR ARRHYTHMIA 20 0.0055
185 PNEUMONIA KLEBSIELLA 10 0.0054
186 PULMONARY CONGESTION 71 0.0054
187 PANCREATIC CYST 10 0.0052
188 CARDIOGENIC SHOCK 75 0.0052
189 BLOOD PRESSURE INADEQUATELY CONTROLLED 31 0.0051
190 BLADDER PAIN 16 0.0050
191 RESPIRATORY DISORDER 150 0.0050
192 GASTROENTERITIS 73 0.0050
193 DIVERTICULUM INTESTINAL HAEMORRHAGIC 11 0.0049
194 SEASONAL ALLERGY 69 0.0049
195 EXERCISE TOLERANCE DECREASED 28 0.0049
196 ACUTE PSYCHOSIS 12 0.0048
197 BACTERIAL INFECTION 90 0.0048
198 FOOD ALLERGY 37 0.0048
199 PSEUDOMONAS INFECTION 41 0.0048
200 CEREBRAL ATROPHY 19 0.0048
201 BRONCHOSPASM 68 0.0048
202 TOXIC EPIDERMAL NECROLYSIS 72 0.0047
203 CONCOMITANT DISEASE PROGRESSION 9 0.0046
204 BLOOD TEST ABNORMAL 64 0.0046
205 CANDIDIASIS 18 0.0045
206 NASAL POLYPS 22 0.0045
207 CORONARY ARTERY THROMBOSIS 9 0.0045
208 PNEUMONIA 1435 0.0044
209 BREAST DISORDER 9 0.0044
210 WOUND COMPLICATION 15 0.0044
211 CREPITATIONS 13 0.0044
212 VENTRICULAR HYPOKINESIA 14 0.0044
213 ATRIAL TACHYCARDIA 9 0.0043
214 MYOPATHY 37 0.0043
215 WHEELCHAIR USER 19 0.0043
216 RHINITIS ALLERGIC 19 0.0043
217 BLOOD CHLORIDE DECREASED 11 0.0043
218 PARANASAL SINUS DISCOMFORT 16 0.0042
219 DERMATITIS ALLERGIC 53 0.0042
220 ACUTE RESPIRATORY FAILURE 81 0.0042
221 NASAL CONGESTION 246 0.0042
222 BLOOD LACTIC ACID INCREASED 22 0.0042
223 DYSPNOEA 2364 0.0042
224 EOSINOPHILIA 73 0.0042
225 ORAL INTAKE REDUCED 10 0.0041
226 ASPIRATION 45 0.0041
227 OSTEOPOROSIS 169 0.0041
228 WOUND SECRETION 16 0.0041
229 SKIN ABRASION 19 0.0040
230 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
231 BLOOD LOSS ANAEMIA 9 0.0040
232 SKIN LACERATION 43 0.0040
233 HAEMODIALYSIS 33 0.0039
234 ARTERIOSCLEROSIS CORONARY ARTERY 26 0.0039
235 OCULAR DISCOMFORT 44 0.0039
236 GRAND MAL CONVULSION 36 0.0039
237 COUGH 1086 0.0039
238 PULMONARY MASS 57 0.0038
239 VENTRICULAR TACHYCARDIA 63 0.0038
240 DYSPNOEA AT REST 11 0.0038
241 ERYSIPELAS 19 0.0038
242 CHEST DISCOMFORT 385 0.0038
243 END STAGE RENAL DISEASE 68 0.0037
244 INCREASED UPPER AIRWAY SECRETION 19 0.0037
245 SYNOVIAL CYST 17 0.0037
246 UPPER RESPIRATORY TRACT INFECTION 170 0.0037
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0037
248 CHEST PAIN 679 0.0037
249 HAEMOPTYSIS 102 0.0037
250 ANOREXIA 47 0.0036
251 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 12 0.0036
252 PNEUMONIA BACTERIAL 33 0.0036
253 ISCHAEMIC CARDIOMYOPATHY 11 0.0036
254 LUNG DISORDER 175 0.0036
255 SINUS DISORDER 70 0.0035
256 ULCER 56 0.0035
257 MYOCARDIAL ISCHAEMIA 40 0.0035
258 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
259 PNEUMONIA VIRAL 11 0.0034
260 EXTRASYSTOLES 24 0.0034
261 VENTRICULAR EXTRASYSTOLES 35 0.0034
262 RESPIRATORY FAILURE 244 0.0033
263 HEARING IMPAIRED 20 0.0033
264 ASCITES 98 0.0033
265 PEPTIC ULCER 11 0.0033
266 CYANOSIS 52 0.0033
267 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
268 ANGINA PECTORIS 93 0.0032
269 HIATUS HERNIA 42 0.0032
270 ATRIOVENTRICULAR BLOCK FIRST DEGREE 14 0.0032
271 HYPOKALAEMIA 149 0.0032
272 ORAL CANDIDIASIS 42 0.0032
273 MULTIPLE ALLERGIES 25 0.0032
274 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
275 MITRAL VALVE INCOMPETENCE 36 0.0032
276 DEPRESSION SUICIDAL 11 0.0032
277 SNORING 12 0.0032
278 CARDIOMEGALY 39 0.0032
279 LUNG INFILTRATION 28 0.0032
280 ANKLE FRACTURE 49 0.0032
281 HYPOXIA 111 0.0031
282 ATRIAL FIBRILLATION 305 0.0031
283 CONGESTIVE CARDIOMYOPATHY 13 0.0031
284 RIB FRACTURE 64 0.0031
285 KNEE ARTHROPLASTY 65 0.0031
286 RESPIRATORY TRACT CONGESTION 49 0.0031
287 OEDEMA MOUTH 10 0.0031
288 CARDIOMYOPATHY 45 0.0030
289 BLOOD IRON DECREASED 36 0.0030
290 ABDOMINAL TENDERNESS 15 0.0030
291 CARDIAC MURMUR 26 0.0030
292 AZOTAEMIA 12 0.0030
293 CORONARY ARTERY STENOSIS 15 0.0030
294 SUDDEN CARDIAC DEATH 10 0.0029
295 HYPERURICAEMIA 12 0.0029
296 CARDIAC FAILURE CONGESTIVE 234 0.0029
297 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
298 GASTROOESOPHAGEAL REFLUX DISEASE 234 0.0029
299 OXYGEN SATURATION DECREASED 163 0.0029
300 PLEURISY 17 0.0029
301 BRONCHITIS 210 0.0028
302 HAEMORRHAGE SUBCUTANEOUS 10 0.0028
303 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
304 DEPRESSED MOOD 148 0.0028
305 MULTIPLE ORGAN DYSFUNCTION SYNDROME 79 0.0028
306 ANGINA UNSTABLE 18 0.0028
307 TRICUSPID VALVE INCOMPETENCE 22 0.0028
308 LUNG INFECTION 43 0.0028
309 STEVENS-JOHNSON SYNDROME 61 0.0027
310 BODY TEMPERATURE DECREASED 27 0.0027
311 RHINORRHOEA 176 0.0027
312 HYPOACUSIS 116 0.0027
313 ILEUS PARALYTIC 12 0.0027
314 NEURALGIA 65 0.0027
315 PYELONEPHRITIS 23 0.0027
316 ATRIAL FLUTTER 21 0.0026
317 DIABETIC NEUROPATHY 13 0.0026
318 PHARMACEUTICAL PRODUCT COMPLAINT 68 0.0026
319 VISUAL DISTURBANCE 15 0.0026
320 VOMITING 1229 0.0026
321 TACHYCARDIA 231 0.0026
322 BUNDLE BRANCH BLOCK LEFT 11 0.0026
323 NEPHROGENIC ANAEMIA 12 0.0026
324 CAROTID ARTERY STENOSIS 9 0.0026
325 MIDDLE INSOMNIA 48 0.0026
326 RHINOVIRUS INFECTION 10 0.0026
327 DIABETES MELLITUS 194 0.0025
328 WEIGHT LOSS POOR 13 0.0025
329 OESOPHAGEAL CANDIDIASIS 10 0.0025
330 APPARENT DEATH 9 0.0025
331 ACIDOSIS 19 0.0025
332 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
333 TOOTH ABSCESS 25 0.0025
334 DRUG INTERACTION 388 0.0024
335 HYPERTONIA 14 0.0024
336 ASPERGILLUS INFECTION 16 0.0024
337 CORONARY ARTERY BYPASS 14 0.0024
338 CONVULSION 138 0.0024
339 TRANSIENT ISCHAEMIC ATTACK 81 0.0024
340 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
341 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
342 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
343 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
344 RENAL FAILURE ACUTE 100 0.0024
345 CATARACT 140 0.0023
346 AORTIC VALVE INCOMPETENCE 10 0.0023
347 CIRCULATORY COLLAPSE 40 0.0023
348 LUNG NEOPLASM 10 0.0023
349 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
350 OROPHARYNGEAL DISCOMFORT 21 0.0023
351 SARCOIDOSIS 11 0.0023
352 RHABDOMYOLYSIS 96 0.0023
353 HYPONATRAEMIA 128 0.0023
354 CATHETERISATION CARDIAC 10 0.0023
355 BODY TEMPERATURE INCREASED 46 0.0023
356 INTENTIONAL PRODUCT MISUSE 196 0.0022
357 SLEEP DISORDER 156 0.0022
358 BLOOD CHOLESTEROL INCREASED 103 0.0022
359 TACHYPNOEA 30 0.0022
360 ASPHYXIA 18 0.0022
361 BLOOD POTASSIUM DECREASED 66 0.0022
362 CORONARY ARTERY DISEASE 66 0.0022
363 PROTHROMBIN TIME PROLONGED 13 0.0022
364 ATELECTASIS 21 0.0022
365 ACCIDENTAL EXPOSURE 9 0.0022
366 EAR PAIN 42 0.0022
367 BLOOD UREA INCREASED 36 0.0021
368 POISONING 27 0.0021
369 MULTI-ORGAN FAILURE 37 0.0021
370 CEREBRAL ISCHAEMIA 11 0.0021
371 SINUSITIS 218 0.0021
372 SPINAL COLUMN STENOSIS 10 0.0021
373 ECONOMIC PROBLEM 32 0.0021
374 GENERALISED OEDEMA 26 0.0021
375 PARTIAL SEIZURES 11 0.0021
376 LEUKOCYTOSIS 38 0.0021
377 PERITONITIS BACTERIAL 21 0.0021
378 PNEUMOTHORAX 33 0.0021
379 RENAL FAILURE CHRONIC 16 0.0021
380 DEPRESSED LEVEL OF CONSCIOUSNESS 82 0.0021
381 ESCHERICHIA INFECTION 17 0.0021
382 METABOLIC DISORDER 12 0.0021
383 MULTIPLE INJURIES 13 0.0021
384 EJECTION FRACTION DECREASED 32 0.0021
385 AUTOIMMUNE DISORDER 20 0.0020
386 SPINAL OSTEOARTHRITIS 18 0.0020
387 MEDICATION ERROR 113 0.0020
388 PHARYNGITIS 25 0.0020
389 AUTOIMMUNE HEPATITIS 14 0.0020
390 HYPOMAGNESAEMIA 28 0.0020
391 CHOKING SENSATION 11 0.0020
392 SENSORY DISTURBANCE 32 0.0020
393 HYPOGAMMAGLOBULINAEMIA 13 0.0020
394 ADRENAL INSUFFICIENCY 24 0.0020
395 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
396 TOXICITY TO VARIOUS AGENTS 328 0.0019
397 VARICOSE VEIN 10 0.0019
398 TYPE 2 DIABETES MELLITUS 65 0.0019
399 JOINT INJURY 41 0.0019
400 METABOLIC ACIDOSIS 61 0.0019
401 ENTEROCOLITIS 11 0.0019
402 DRY MOUTH 154 0.0019
403 HAEMATEMESIS 48 0.0019
404 HYPOVOLAEMIA 11 0.0019
405 ENCEPHALOPATHY 46 0.0019
406 PULMONARY HYPERTENSION 39 0.0019
407 COMPRESSION FRACTURE 10 0.0019
408 HYPERGLYCAEMIA 68 0.0019
409 HYPERCALCAEMIA 23 0.0019
410 EYE PRURITUS 62 0.0018
411 HERPES ZOSTER 106 0.0018
412 MALAISE 806 0.0018
413 HYPERTENSION 388 0.0018
414 BRAIN OEDEMA 23 0.0018
415 SPINAL COMPRESSION FRACTURE 15 0.0018
416 ARTERIOSCLEROSIS 17 0.0018
417 APNOEA 14 0.0018
418 ACUTE MYOCARDIAL INFARCTION 53 0.0018
419 INJURY 126 0.0018
420 PULMONARY HAEMORRHAGE 14 0.0018
421 HYPOTHYROIDISM 57 0.0018
422 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
423 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
424 RESPIRATORY DISTRESS 49 0.0018
425 ATAXIA 21 0.0018
426 FEMORAL NECK FRACTURE 9 0.0018
427 MICTURITION URGENCY 20 0.0017
428 OEDEMA PERIPHERAL 213 0.0017
429 HEART RATE INCREASED 172 0.0017
430 ARRHYTHMIA 82 0.0017
431 POST PROCEDURAL INFECTION 14 0.0017
432 STRESS CARDIOMYOPATHY 10 0.0017
433 VIRAL INFECTION 57 0.0017
434 DYSPHONIA 100 0.0017
435 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
436 SKIN INFECTION 19 0.0017
437 MENTAL IMPAIRMENT 41 0.0017
438 LIVER FUNCTION TEST INCREASED 36 0.0017
439 PULMONARY OEDEMA 75 0.0017
440 MOTOR DYSFUNCTION 17 0.0017
441 WHITE BLOOD CELL COUNT INCREASED 64 0.0017
442 RESTLESSNESS 61 0.0017
443 TORSADE DE POINTES 13 0.0017
444 MENTAL STATUS CHANGES 46 0.0017
445 PLATELET COUNT ABNORMAL 10 0.0017
446 BLOOD CREATININE INCREASED 108 0.0017
447 HYPOKINESIA 24 0.0017
448 CARDIAC FAILURE ACUTE 11 0.0016
449 SNEEZING 37 0.0016
450 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
451 CARDIAC FAILURE 132 0.0016
452 ARTHROPATHY 91 0.0016
453 PHARYNGEAL SWELLING 16 0.0016
454 INFLUENZA 182 0.0016
455 HEPATOMEGALY 16 0.0016
456 SPLENOMEGALY 19 0.0016
457 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
458 DISORIENTATION 64 0.0016
459 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
460 EYE MOVEMENT DISORDER 11 0.0016
461 DRUG ABUSE 133 0.0016
462 RESPIRATORY ARREST 44 0.0016
463 WRIST FRACTURE 19 0.0016
464 BLOOD PRESSURE FLUCTUATION 38 0.0016
465 APHONIA 22 0.0016
466 ABDOMINAL DISTENSION 164 0.0016
467 ACUTE CORONARY SYNDROME 13 0.0016
468 PULMONARY FIBROSIS 30 0.0016
469 DELIRIUM 54 0.0016
470 LOW DENSITY LIPOPROTEIN INCREASED 12 0.0015
471 HYPOGLYCAEMIA 75 0.0015
472 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
473 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
474 HALLUCINATION, VISUAL 32 0.0015
475 SUDDEN DEATH 16 0.0015
476 DRUG INTOLERANCE 146 0.0015
477 UNRESPONSIVE TO STIMULI 39 0.0015
478 RENAL CYST 12 0.0015
479 CONJUNCTIVITIS 28 0.0015
480 MAJOR DEPRESSION 11 0.0015
481 CARDIOVASCULAR DISORDER 38 0.0015
482 BODY HEIGHT DECREASED 16 0.0015
483 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
484 DERMATITIS CONTACT 17 0.0015
485 RECTAL HAEMORRHAGE 64 0.0015
486 CHOKING 29 0.0015
487 NOCTURIA 18 0.0015
488 PNEUMONIA ASPIRATION 37 0.0015
489 GENERAL PHYSICAL HEALTH DETERIORATION 171 0.0015
490 DECUBITUS ULCER 12 0.0015
491 SEPSIS 164 0.0015
492 DRUG EXPOSURE DURING PREGNANCY 50 0.0015
493 CELLULITIS 74 0.0015
494 ASPARTATE AMINOTRANSFERASE INCREASED 78 0.0015
495 DYSARTHRIA 55 0.0015
496 BLOOD PRESSURE ABNORMAL 29 0.0015
497 OCULAR HYPERAEMIA 69 0.0015
498 SINUS BRADYCARDIA 14 0.0014
499 HEMIPLEGIA 12 0.0014
500 HYPERTHERMIA 11 0.0014
501 TREMOR 239 0.0014
502 SHOCK 33 0.0014
503 BLOOD SODIUM DECREASED 27 0.0014
504 CONDITION AGGRAVATED 435 0.0014
505 INFUSION SITE SWELLING 9 0.0014
506 ATRIOVENTRICULAR BLOCK 11 0.0014
507 CANDIDA INFECTION 24 0.0014
508 HEART RATE IRREGULAR 32 0.0014
509 DIVERTICULUM 10 0.0014
510 INTENTIONAL OVERDOSE 90 0.0014
511 RESPIRATORY DEPRESSION 17 0.0014
512 CORONARY ARTERY OCCLUSION 19 0.0014
513 TONGUE DISORDER 10 0.0014
514 CAESAREAN SECTION 16 0.0014
515 HAEMATURIA 47 0.0014
516 MASS 19 0.0014
517 ANAPHYLACTIC SHOCK 35 0.0014
518 SECRETION DISCHARGE 17 0.0014
519 MUSCULOSKELETAL CHEST PAIN 21 0.0014
520 C-REACTIVE PROTEIN INCREASED 49 0.0013
521 POLYURIA 11 0.0013
522 BLOOD PRESSURE INCREASED 205 0.0013
523 FEELING COLD 37 0.0013
524 REBOUND EFFECT 15 0.0013
525 DYSPEPSIA 130 0.0013
526 FLUID RETENTION 67 0.0013
527 PLEURAL EFFUSION 80 0.0013
528 NERVOUS SYSTEM DISORDER 41 0.0013
529 INTERSTITIAL LUNG DISEASE 63 0.0013
530 IRON DEFICIENCY ANAEMIA 12 0.0013
531 HEMIPARESIS 22 0.0013
532 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
533 DEPRESSION 294 0.0013
534 CARDIO-RESPIRATORY ARREST 54 0.0013
535 ELECTROLYTE IMBALANCE 15 0.0013
536 WEIGHT INCREASED 288 0.0013
537 NEPHROPATHY 12 0.0013
538 CARDIAC ARREST 106 0.0013
539 ANURIA 11 0.0013
540 DYSURIA 47 0.0013
541 BLOOD MAGNESIUM DECREASED 11 0.0013
542 MUSCLE STRAIN 11 0.0013
543 HAEMORRHAGE INTRACRANIAL 19 0.0013
544 DYSSTASIA 37 0.0013
545 DRUG SCREEN POSITIVE 10 0.0013
546 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
547 PYREXIA 436 0.0013
548 LOW BIRTH WEIGHT BABY 10 0.0013
549 GINGIVAL PAIN 10 0.0013
550 NASOPHARYNGITIS 231 0.0013
551 PULMONARY EMBOLISM 119 0.0013
552 LIMB INJURY 34 0.0013
553 URINARY INCONTINENCE 37 0.0012
554 THROAT IRRITATION 56 0.0012
555 PALPITATIONS 146 0.0012
556 DYSPHAGIA 118 0.0012
557 PAIN 763 0.0012
558 HERNIA 24 0.0012
559 COMPLETED SUICIDE 103 0.0012
560 MUSCLE DISORDER 10 0.0012
561 WEIGHT DECREASED 344 0.0012
562 THROMBOSIS 99 0.0012
563 RENAL TUBULAR NECROSIS 12 0.0012
564 GASTRITIS 32 0.0012
565 HYPOCALCAEMIA 23 0.0012
566 TENDON RUPTURE 15 0.0012
567 LIGAMENT SPRAIN 12 0.0012
568 BLOOD URINE PRESENT 23 0.0012
569 HAEMATOCRIT DECREASED 24 0.0012
570 ILEUS 15 0.0012
571 HEPATIC FUNCTION ABNORMAL 45 0.0012
572 COAGULOPATHY 20 0.0012
573 LOCALISED INFECTION 29 0.0012
574 MENTAL DISORDER 52 0.0012
575 OSTEOPENIA 18 0.0012
576 SWELLING 111 0.0012
577 IMPAIRED QUALITY OF LIFE 17 0.0012
578 DEVICE FAILURE 18 0.0012
579 MELAENA 26 0.0012
580 HAEMODYNAMIC INSTABILITY 9 0.0012
581 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
582 DRUG LEVEL DECREASED 12 0.0012
583 LIVER DISORDER 52 0.0012
584 BLOOD POTASSIUM INCREASED 19 0.0012
585 SQUAMOUS CELL CARCINOMA 11 0.0012
586 GASTRIC ULCER 22 0.0012
587 HYPOTENSION 232 0.0012
588 OVERDOSE 249 0.0012
589 ANXIETY 327 0.0011
590 NO THERAPEUTIC RESPONSE 14 0.0011
591 OROPHARYNGEAL PAIN 106 0.0011
592 HYPERKALAEMIA 40 0.0011
593 ANAPHYLACTIC REACTION 63 0.0011
594 BLOOD ALBUMIN DECREASED 9 0.0011
595 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
596 HYPOAESTHESIA ORAL 17 0.0011
597 DEHYDRATION 150 0.0011
598 TRANSAMINASES INCREASED 25 0.0011
599 RENAL FAILURE 149 0.0011
600 SUICIDE ATTEMPT 68 0.0011
601 LABORATORY TEST ABNORMAL 33 0.0011
602 ANAEMIA 213 0.0011
603 DECREASED ACTIVITY 12 0.0011
604 NEPHROLITHIASIS 51 0.0011
605 SINUS CONGESTION 15 0.0011
606 DEMENTIA 31 0.0011
607 ECZEMA 58 0.0011
608 PHARYNGEAL OEDEMA 17 0.0011
609 THYROID DISORDER 17 0.0011
610 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
611 BONE DISORDER 20 0.0011
612 BACTERAEMIA 13 0.0011
613 BLOOD GLUCOSE FLUCTUATION 12 0.0011
614 ROTATOR CUFF SYNDROME 14 0.0011
615 ACCIDENT 13 0.0011
616 DENTAL CARIES 12 0.0011
617 DRY THROAT 11 0.0011
618 MYOCARDIAL INFARCTION 188 0.0011
619 AMNESIA 70 0.0011
620 ARTHRITIS 84 0.0011
621 SOMNOLENCE 215 0.0011
622 DERMATITIS ATOPIC 56 0.0011
623 HAEMOGLOBIN DECREASED 109 0.0011
624 SPINAL DISORDER 10 0.0011
625 GASTROINTESTINAL HAEMORRHAGE 88 0.0011
626 MUSCULOSKELETAL STIFFNESS 92 0.0010
627 CONTUSION 101 0.0010
628 ABDOMINAL PAIN 244 0.0010
629 GAIT INABILITY 35 0.0010
630 HAEMATOMA 27 0.0010
631 INCONTINENCE 11 0.0010
632 JAUNDICE 28 0.0010
633 SYNCOPE 104 0.0010
634 MUSCULAR WEAKNESS 118 0.0010
635 BRADYCARDIA 55 0.0010
636 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
637 TENDONITIS 16 0.0010
638 DIZZINESS POSTURAL 10 0.0010
639 DELUSION 16 0.0010
640 PREMATURE BABY 31 0.0010
641 VITAMIN D DEFICIENCY 10 0.0010
642 HEPATIC STEATOSIS 19 0.0010
643 PRODUCT QUALITY ISSUE 138 0.0010
644 FAECES DISCOLOURED 22 0.0010
645 ABASIA 25 0.0010
646 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
647 PROCEDURAL PAIN 28 0.0010
648 INFUSION SITE PAIN 13 0.0010
649 BLADDER DISORDER 10 0.0010
650 FOOT FRACTURE 19 0.0010
651 PAIN IN EXTREMITY 295 0.0010
652 FALL 332 0.0010
653 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
654 PNEUMONITIS 27 0.0010
655 ADVERSE DRUG REACTION 89 0.0010
656 DRUG-INDUCED LIVER INJURY 31 0.0010
657 EPILEPSY 30 0.0010
658 HEAD INJURY 31 0.0010
659 NEUTROPHIL COUNT INCREASED 10 0.0010
660 ORTHOSTATIC HYPOTENSION 17 0.0010
661 DIVERTICULITIS 27 0.0010
662 PRURITUS GENERALISED 21 0.0010
663 TREATMENT NONCOMPLIANCE 53 0.0010
664 BLOOD PRESSURE DECREASED 64 0.0010
665 PANIC ATTACK 35 0.0010
666 TENDERNESS 10 0.0010
667 URINARY RETENTION 32 0.0010
668 IMPAIRED GASTRIC EMPTYING 13 0.0010
669 INFECTION 137 0.0009
670 JOINT DISLOCATION 10 0.0009
671 DIZZINESS 470 0.0009
672 PRODUCT ADMINISTRATION ERROR 19 0.0009
673 COLON CANCER 14 0.0009
674 HYPERSENSITIVITY 174 0.0009
675 POLLAKIURIA 39 0.0009
676 CHRONIC KIDNEY DISEASE 71 0.0009
677 CHOLECYSTITIS 11 0.0009
678 SKIN REACTION 13 0.0009
679 OSTEOARTHRITIS 39 0.0009
680 DISCOMFORT 56 0.0009
681 LOCAL SWELLING 16 0.0009
682 EPISTAXIS 68 0.0009
683 BURSITIS 11 0.0009
684 CONSTIPATION 197 0.0009
685 COMA 43 0.0009
686 HYPOTONIA 9 0.0009
687 CEREBRAL INFARCTION 22 0.0009
688 AGITATION 66 0.0009
689 SPINAL FRACTURE 18 0.0009
690 INSOMNIA 237 0.0009
691 ASTHENIA 334 0.0009
692 THROAT TIGHTNESS 24 0.0009
693 PRODUCT TASTE ABNORMAL 12 0.0009
694 CONFUSIONAL STATE 143 0.0009
695 ABDOMINAL DISCOMFORT 148 0.0009
696 ANHEDONIA 23 0.0009
697 THERAPEUTIC RESPONSE DECREASED 53 0.0009
698 HAEMORRHOIDS 17 0.0009
699 PERIPHERAL SWELLING 134 0.0009
700 HYPERHIDROSIS 112 0.0009
701 LETHARGY 50 0.0009
702 HYPOAESTHESIA 130 0.0009
703 CARDIAC DISORDER 81 0.0009
704 BACK PAIN 201 0.0009
705 SWOLLEN TONGUE 27 0.0009
706 MATERNAL EXPOSURE DURING PREGNANCY 77 0.0009
707 BACK DISORDER 14 0.0009
708 LIVER FUNCTION TEST ABNORMAL 25 0.0009
709 UNEVALUABLE EVENT 65 0.0009
710 MUSCULOSKELETAL PAIN 45 0.0009
711 LUNG NEOPLASM MALIGNANT 35 0.0009
712 COLD SWEAT 15 0.0009
713 STAPHYLOCOCCAL INFECTION 28 0.0008
714 DRUG ERUPTION 15 0.0008
715 DIALYSIS 12 0.0008
716 PANCREATITIS ACUTE 19 0.0008
717 LOSS OF CONSCIOUSNESS 108 0.0008
718 NERVOUSNESS 44 0.0008
719 INTENTIONAL DOSE OMISSION 24 0.0008
720 RED BLOOD CELL COUNT DECREASED 24 0.0008
721 IMMUNE SYSTEM DISORDER 11 0.0008
722 SYNOVITIS 15 0.0008
723 GASTROENTERITIS VIRAL 15 0.0008
724 TOOTHACHE 15 0.0008
725 DYSTONIA 16 0.0008
726 PERICARDIAL EFFUSION 19 0.0008
727 RENAL IMPAIRMENT 69 0.0008
728 CYSTITIS 26 0.0008
729 FEELING HOT 50 0.0008
730 KIDNEY INFECTION 16 0.0008
731 SMALL INTESTINAL OBSTRUCTION 10 0.0008
732 NEUROPATHY PERIPHERAL 77 0.0008
733 DISABILITY 16 0.0008
734 URINARY TRACT INFECTION 138 0.0008
735 HIP FRACTURE 26 0.0008
736 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
737 SEIZURE 93 0.0008
738 GAIT DISTURBANCE 154 0.0008
739 ORAL PAIN 18 0.0008
740 MUSCLE SPASMS 147 0.0008
741 DISEASE RECURRENCE 38 0.0008
742 NAUSEA 632 0.0008
743 ABNORMAL DREAMS 22 0.0008
744 CHOLECYSTECTOMY 9 0.0008
745 NECK PAIN 44 0.0008
746 CARPAL TUNNEL SYNDROME 11 0.0008
747 CHILLS 92 0.0008
748 BLISTER 44 0.0008
749 POST PROCEDURAL COMPLICATION 15 0.0008
750 LYMPHOMA 12 0.0008
751 RENAL DISORDER 36 0.0008
752 AGGRESSION 38 0.0008
753 FLUID OVERLOAD 11 0.0008
754 HALLUCINATION, AUDITORY 12 0.0008
755 DYSGEUSIA 56 0.0008
756 COGNITIVE DISORDER 35 0.0007
757 MOVEMENT DISORDER 24 0.0007
758 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
759 BALANCE DISORDER 64 0.0007
760 MYALGIA 124 0.0007
761 LOWER LIMB FRACTURE 14 0.0007
762 APHASIA 22 0.0007
763 ADVERSE EVENT 67 0.0007
764 CEREBROVASCULAR ACCIDENT 123 0.0007
765 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
766 ELECTROCARDIOGRAM QT PROLONGED 26 0.0007
767 SWELLING FACE 47 0.0007
768 INSURANCE ISSUE 11 0.0007
769 MOUTH ULCERATION 15 0.0007
770 NEUTROPHIL COUNT DECREASED 29 0.0007
771 ACUTE KIDNEY INJURY 108 0.0007
772 PARAESTHESIA 111 0.0007
773 PRESCRIBED UNDERDOSE 14 0.0007
774 CHOLELITHIASIS 23 0.0007
775 DECREASED APPETITE 162 0.0007
776 HEPATIC FAILURE 21 0.0007
777 RASH GENERALISED 18 0.0007
778 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
779 ARTHRALGIA 288 0.0007
780 HYPERTHYROIDISM 10 0.0007
781 SEPTIC SHOCK 30 0.0007
782 MUCOSAL INFLAMMATION 18 0.0007
783 VISION BLURRED 94 0.0007
784 ACCIDENTAL OVERDOSE 25 0.0007
785 LACTIC ACIDOSIS 22 0.0007
786 PSYCHOTIC DISORDER 20 0.0007
787 DEEP VEIN THROMBOSIS 44 0.0007
788 RENAL INJURY 20 0.0007
789 THIRST 12 0.0007
790 JOINT RANGE OF MOTION DECREASED 9 0.0007
791 BLOOD GLUCOSE DECREASED 32 0.0007
792 GINGIVAL BLEEDING 9 0.0007
793 FIBROMYALGIA 16 0.0007
794 PRESYNCOPE 16 0.0007
795 HEART RATE DECREASED 23 0.0007
796 HIP ARTHROPLASTY 10 0.0007
797 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
798 URTICARIA 109 0.0006
799 HALLUCINATION 49 0.0006
800 DEAFNESS 17 0.0006
801 CYTOKINE RELEASE SYNDROME 13 0.0006
802 LIMB DISCOMFORT 20 0.0006
803 HUNGER 9 0.0006
804 FEMUR FRACTURE 20 0.0006
805 SUICIDAL IDEATION 59 0.0006
806 INFLUENZA LIKE ILLNESS 53 0.0006
807 GASTRIC DISORDER 22 0.0006
808 HAEMORRHAGE 67 0.0006
809 PAIN IN JAW 18 0.0006
810 SPEECH DISORDER 33 0.0006
811 FEELING JITTERY 12 0.0006
812 NEUROTOXICITY 11 0.0006
813 BURNING SENSATION 44 0.0006
814 PALLOR 17 0.0006
815 PANCREATITIS 33 0.0006
816 INTENTIONAL DRUG MISUSE 13 0.0006
817 SKIN ULCER 16 0.0006
818 GALLBLADDER DISORDER 11 0.0006
819 INCORRECT ROUTE OF DRUG ADMINISTRATION 22 0.0006
820 DRUG EFFECT DECREASED 33 0.0006
821 MOBILITY DECREASED 44 0.0006
822 PRODUCT DOSE OMISSION ISSUE 180 0.0006
823 INTESTINAL OBSTRUCTION 23 0.0006
824 METASTASES TO BONE 10 0.0006
825 OSTEOMYELITIS 11 0.0006
826 RESTLESS LEGS SYNDROME 11 0.0006
827 THERAPY CESSATION 31 0.0006
828 VISUAL ACUITY REDUCED 20 0.0006
829 THERAPY NON-RESPONDER 27 0.0006
830 BONE PAIN 35 0.0006
831 FEAR 16 0.0006
832 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
833 HYPERSOMNIA 17 0.0006
834 FATIGUE 461 0.0006
835 HEADACHE 370 0.0006
836 DRUG INEFFECTIVE 777 0.0006
837 DRUG DISPENSING ERROR 9 0.0006
838 JOINT SWELLING 71 0.0006
839 ANGIOEDEMA 26 0.0006
840 HYPOPHAGIA 15 0.0006
841 HEPATITIS 15 0.0006
842 FEELING ABNORMAL 140 0.0006
843 PRODUCT USE IN UNAPPROVED INDICATION 144 0.0006
844 GLOSSODYNIA 13 0.0006
845 ABNORMAL BEHAVIOUR 23 0.0006
846 PARANOIA 10 0.0006
847 DRUG EFFECT INCOMPLETE 21 0.0006
848 ILL-DEFINED DISORDER 35 0.0006
849 CHROMATURIA 13 0.0006
850 INCREASED APPETITE 11 0.0006
851 ROAD TRAFFIC ACCIDENT 24 0.0006
852 CHOLESTASIS 11 0.0006
853 DERMATITIS 12 0.0006
854 DRUG DEPENDENCE 92 0.0006
855 LIP SWELLING 19 0.0006
856 FUNGAL INFECTION 19 0.0006
857 METASTASES TO LIVER 10 0.0006
858 EYE PAIN 32 0.0006
859 RETCHING 12 0.0006
860 MEMORY IMPAIRMENT 77 0.0006
861 BLOOD GLUCOSE INCREASED 105 0.0006
862 BLOOD BILIRUBIN INCREASED 15 0.0006
863 DRUG DOSE OMISSION 91 0.0005
864 RASH 238 0.0005
865 DRUG RESISTANCE 14 0.0005
866 OFF LABEL USE 471 0.0005
867 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
868 ILLNESS 55 0.0005
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 96 0.0005
870 PHOTOPHOBIA 10 0.0005
871 PERITONITIS 11 0.0005
872 LACRIMATION INCREASED 16 0.0005
873 ABDOMINAL PAIN UPPER 109 0.0005
874 EAR INFECTION 14 0.0005
875 PROTEINURIA 10 0.0005
876 VERTIGO 32 0.0005
877 MIGRAINE 50 0.0005
878 WRONG TECHNIQUE IN DRUG USAGE PROCESS 19 0.0005
879 TINNITUS 24 0.0005
880 DIARRHOEA 337 0.0005
881 DRUG PRESCRIBING ERROR 10 0.0005
882 OSTEONECROSIS 17 0.0005
883 EATING DISORDER 11 0.0005
884 ABDOMINAL PAIN LOWER 13 0.0005
885 BREAST CANCER 47 0.0005
886 INFLAMMATION 26 0.0005
887 UPPER LIMB FRACTURE 10 0.0005
888 THROMBOCYTOPENIA 56 0.0005
889 DISTURBANCE IN ATTENTION 27 0.0005
890 DIPLOPIA 13 0.0005
891 INFUSION RELATED REACTION 33 0.0005
892 PLATELET COUNT DECREASED 53 0.0005
893 SEDATION 13 0.0005
894 FEEDING DISORDER 10 0.0005
895 COLITIS ULCERATIVE 22 0.0005
896 DYSKINESIA 20 0.0005
897 BLOOD GLUCOSE ABNORMAL 9 0.0005
898 EMOTIONAL DISORDER 15 0.0005
899 OSTEONECROSIS OF JAW 12 0.0005
900 EYE SWELLING 18 0.0005
901 PANCYTOPENIA 27 0.0005
902 LYMPHADENOPATHY 17 0.0005
903 GASTROINTESTINAL DISORDER 43 0.0005
904 RASH PRURITIC 26 0.0005
905 NEOPLASM MALIGNANT 32 0.0005
906 HEPATIC CIRRHOSIS 9 0.0005
907 BONE DENSITY DECREASED 15 0.0005
908 ERECTILE DYSFUNCTION 12 0.0005
909 TARDIVE DYSKINESIA 13 0.0005
910 PRODUCT PRESCRIBING ISSUE 10 0.0005
911 SKIN DISORDER 15 0.0004
912 TOOTH DISORDER 10 0.0004
913 RASH MACULO-PAPULAR 10 0.0004
914 PRURITUS 171 0.0004
915 HOSPITALISATION 68 0.0004
916 AGEUSIA 11 0.0004
917 SKIN LESION 12 0.0004
918 MUSCLE TWITCHING 10 0.0004
919 IRRITABILITY 26 0.0004
920 FOETAL EXPOSURE DURING PREGNANCY 35 0.0004
921 DRUG ADMINISTRATION ERROR 13 0.0004
922 FLUSHING 43 0.0004
923 BLINDNESS 17 0.0004
924 SKIN DISCOLOURATION 19 0.0004
925 HEPATOTOXICITY 9 0.0004
926 EXTRAPYRAMIDAL DISORDER 10 0.0004
927 EXPOSURE DURING PREGNANCY 25 0.0004
928 DEATH 345 0.0004
929 INCORRECT DOSE ADMINISTERED 91 0.0004
930 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
931 HEPATIC ENZYME INCREASED 27 0.0004
932 COLITIS 15 0.0004
933 EYE DISORDER 13 0.0004
934 EXPIRED PRODUCT ADMINISTERED 13 0.0004
935 VISUAL IMPAIRMENT 48 0.0004
936 STOMATITIS 23 0.0004
937 INJECTION SITE SWELLING 29 0.0004
938 RASH ERYTHEMATOUS 18 0.0004
939 NIGHTMARE 13 0.0004
940 BREAST CANCER FEMALE 10 0.0004
941 HOT FLUSH 28 0.0004
942 FLATULENCE 21 0.0004
943 DEVICE MALFUNCTION 26 0.0004
944 ERYTHEMA 76 0.0004
945 PRODUCT USE ISSUE 68 0.0004
946 DRY EYE 18 0.0004
947 CRYING 13 0.0004
948 SKIN EXFOLIATION 30 0.0004
949 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
950 PSORIASIS 46 0.0004
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
952 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
953 CEREBRAL HAEMORRHAGE 12 0.0003
954 FREQUENT BOWEL MOVEMENTS 9 0.0003
955 EMOTIONAL DISTRESS 40 0.0003
956 DISEASE PROGRESSION 39 0.0003
957 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
958 LEUKOPENIA 16 0.0003
959 NEUTROPENIA 43 0.0003
960 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
961 RHEUMATOID ARTHRITIS 35 0.0003
962 HAEMATOCHEZIA 17 0.0003
963 INJECTION SITE PAIN 92 0.0003
964 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
965 ANGER 10 0.0003
966 PRODUCT DOSE OMISSION 19 0.0003
967 ALOPECIA 57 0.0003
968 UNDERDOSE 21 0.0003
969 RASH MACULAR 10 0.0003
970 INJECTION SITE PRURITUS 19 0.0003
971 EYE IRRITATION 16 0.0003
972 VAGINAL HAEMORRHAGE 12 0.0003
973 SURGERY 16 0.0003
974 COVID-19 47 0.0003
975 EXTRA DOSE ADMINISTERED 10 0.0002
976 PRODUCT SUBSTITUTION ISSUE 14 0.0002
977 WITHDRAWAL SYNDROME 10 0.0002
978 THERAPY INTERRUPTED 17 0.0002
979 DRY SKIN 30 0.0002
980 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
981 INJECTION SITE REACTION 15 0.0002
982 TREATMENT FAILURE 18 0.0002
983 NO ADVERSE EVENT 37 0.0002
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
985 INJECTION SITE ERYTHEMA 23 0.0002
986 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
987 INJECTION SITE BRUISING 14 0.0002
988 DRUG WITHDRAWAL SYNDROME 13 0.0001
989 ACNE 11 0.0001
990 FEBRILE NEUTROPENIA 9 0.0001
991 DEVICE ISSUE 11 0.0001
992 INJECTION SITE HAEMORRHAGE 9 0.0001
993 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001